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Aims Coronary computed tomographic angiography (CCTA) has become an important tool for non-invasive diagnosis of cor-
onary artery disease (CAD). Coronary dominance can be assessed by CCTA; however, the predictive value of coronary
dominance is controversially discussed. The aim of this study was to evaluate the prevalence and prognosis of coronary
dominance in a large prospective, international multicentre cohort of patients undergoing CCTA.
Methods
and results
The study population consisted of 6382 patients with or without CAD (47% females, 53% males, mean age 56.9+12.3
years) who underwent CCTA and were followed over a period of 60 months. Right or left coronary dominance was
determined. Right dominance was present in 91% (n ¼ 5817) and left in 9% (n ¼ 565) of the study population. At the
end of follow-up, outcome in patients with obstructive CAD (.50% luminal stenosis) and right dominance was
similar compared with patients with left dominance [hazard ratio (HR) 0.46, 95% CI 0.16–1.32, P ¼ 0.15]. Furthermore,
no differences were observed for the type of coronary dominance in patients with non-obstructive CAD (HR 0.95, 95%
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CI 0.41–2.21, P ¼ 0.8962) or normal coronary arteries (HR 1.04, 95% CI 0.68–1.59, P ¼ 0.9). Subgroup analysis in
patients with left main disease revealed an elevated hazard of the combined endpoint for left dominance (HR 6.45,
95% CI 1.66–25.0, P ¼ 0.007), but not for right dominance.
Conclusion In our study population, survival after 5 years of follow-up did not differ significantly between patients with left or right cor-
onary dominance. Thus, assessment of coronary vessel dominance by CCTA may not enhance risk stratification in patients
with normal coronary arteries or obstructive CAD, but may add prognostic information for specific subpopulations.
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Introduction
Coronary computed tomographic angiography (CCTA) has recent-
ly been introduced as a highly accurate1 – 4 and prognostically
robust5 – 8 non-invasive imaging modality for the assessment of cor-
onary artery disease (CAD). The CONFIRM (COronary CT Angi-
ography EvaluatioN For Clinical Outcomes: An InteRnational
Multicenter) registry enrolled ≥20 000 patients from 12 centres
across North America, Europe, and Asia with suspected CAD
who underwent a ≥64-detector row CCTA, and is the first pro-
spective database evaluating the prognostic role of CCTA.9 Coron-
ary artery dominance is determined according to the coronary
artery that emits the posterior descending artery. Right dominance
is the most prevalent pattern of coronary circulation and is found in
72–90% of individuals, while prevalence of left dominance is
reported to be 8–33%, whereas co-dominance has 3–7% of
population prevalence.10 The relatively low prevalence of left dom-
inance in the general population and the decreasing prevalence of a
left dominant or co-dominant coronary system with age have raised
the question whether this variant may reflect a biological disadvan-
tage relative to right dominance, and recent studies have hypothe-
sized that left dominance may represent less well-balanced
circulation with more myocardium at risk in acute coronary syn-
dromes (ACSs).11 Indeed, a previous study of 27 289 patients
undergoing cardiac catheterization for ACS demonstrated that
left dominance was associated with an increased hazard of death
during a 3.5-year follow-up,12 and a US registry reported that left
dominance and co-dominance were associated with increased
in-hospital mortality in 207 926 patients undergoing percutaneous
coronary intervention (PCI) for ACS.13 However, this work has
been based on conventional angiograms. Since it is often difficult
to delineate the course of coronary arteries by angiography
because it only provides a two-dimensional view of a three-
dimensional structure, the present study analysed coronary domin-
ance and outcome by multidetector coronary CCTA that not only
provides information about the presence and degree of coronary
stenosis, but also allows to see the origin and course of coronary ar-
teries by a three-dimensional display of anatomy thereby permitting
the determination of coronary artery variations.14 – 17 Although
coronary vessel dominance is easily assessed on coronary CCTA,
there is sparse information about the prognostic value of coronary
vessel dominance in patients referred for CCTA. Therefore, the
goal of the present study was to assess the prevalence and prognosis
of coronary dominance in a large prospective, international multi-
centre cohort of patients undergoing CCTA.
Methods
Study design, patients, and outcomemeasures
This study represents 6382 patients from the CONFIRM registry. Briefly,
CONFIRM enrolled consecutive adults .18 years of age between 2005
and 2009 who underwent≥64-detector row CCTA for suspected CAD
at 12 centres in six countries (Canada, Germany, Italy, Korea, Switzer-
land, and the USA). Details of the CONFIRM registry design and data
elements have been published.9,18 –20 Patients with no CAD, non-
obstructive, obstructive, and severe obstructive CAD where coronary
dominance had been assessed were included in the present analysis.
Patients with a balanced coronary artery system were excluded from
the analysis, because of the low number of patients in this group. Cases
with missing data on dominance were excluded from analysis; therefore,
6382 remaining individuals with and without CAD were included for the
final analyses. The primary clinical endpoint of the study was a composite
of all-cause mortality, non-fatal myocardial infarction (MI), and early and
late coronary revascularizations. Non-fatal MI was defined as evidence of
myocardial necrosis consistent with myocardial ischaemia, as detected by
changes in cardiac biomarkers together with symptoms of ischaemia,
ECG changes, or imaging evidence, according to the ESC/ACCF/AHA/
WHF consensus document on the universal definition of non-fatal
MI.21 Notably, in the CONFIRM registry, post-CCTA treatment regi-
mens were not mandated and our database did not include information
on previous or post-CCTA functional testing results. The study complies
with the Declaration of Helsinki, and patient consent or a waiver of
informed consent (as per recommendations of each institutional
review board) was obtained at each site in keeping with site-specific
regulations.
Data acquisition, image reconstruction, and
CCTA analysis
CCTA scanners used in the CONFIRM registry and data acquisition for
CCTA have been described in detail previously.9 Image interpretation
was uniformly performed at each site according to the Society of Cardio-
vascular Computed Tomography guidelines22 by at least one highly
experienced imager who was level III equivalent and/or board certified
in cardiovascular computed tomography. Dominance was determined
independently at each participating site. The coronary artery system
was classified as a right dominant if the right coronary artery (RCA), as
a left dominant if the left circumflex coronary artery (LCx), or as a
co-dominant if RCA and LCx gave rise to the posterior descending
artery. Each site performed per-segment analysis for individual coronary
artery segments by using a 16-segment model. ACAD was defined as the
presence of any plaque. Coronary atherosclerotic lesions were quanti-
fied for lumen diameter stenosis by visual estimation and graded as
none (0% luminal stenosis), mild (1–49%), moderate (50–69%), or
severe (.70%). A coronary lesion compromising the lumen by .50%
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was defined as obstructive. Vessels were classified into four arterial ter-
ritories: left main artery (LM), left anterior descending artery (LAD), LCx,
and RCA. Obstructive CAD in the diagonal branches, obtuse marginal
branches, and posterolateral branches was considered as part of the
LAD, LCx, and RCA system, respectively. The posterior descending
artery was considered as part of the RCA or LCx system, depending
on the coronary artery dominance. A.50% stenosis in the LM was con-
sidered obstructive in all models. Individuals manifesting obstructive
CAD were further categorized as having one-, two-, and three-vessel
disease or left main disease. For the purposes of the study analysis, a
left main coronary stenosis of≥50% was considered equivalent to three-
vessel CAD.
Statistical analysis
SPSS version 12.0 and 17.0 (SPSS, Inc., Chicago, IL, USA) and SAS version
9.2 (SAS Institute, Cary, NC, USA) were used for all statistical analyses.
Categorical variables are presented as frequencies and continuous
variables as mean+ SD. Variables were compared with x2 statistic for
categorical variables and by Student’s unpaired t-test, Wilcoxon/
Mann–Whitney non-parametric test, or median comparison test where
appropriate for continuous variables. The Kaplan–Meier method and the
log-rank A Cox proportional hazards analysis were used to compare
cumulative event-free survival by dominance in patients without signifi-
cant CAD on CCTA and in those with significant CAD on CCTA. The
primary outcome variable was a composite endpoint of all-cause mortal-
ity, non-fatal MI, and revascularization. Multivariable analyses were calcu-
lated with the multivariabe Cox regression model for prediction of the
combined endpoint (with 95% confidence intervals). According to uni-
variate significance and baseline differences between groups, risk
factors such as age, male gender, hypertension, dyslipidaemia, diabetes,
and smoking were included in the multivariate model. Furthermore,
the prognostic value of severity of stenosis and significant stenosis loca-
tion were determined for patients with a right dominant coronary artery
system and patients with a left dominant coronary artery system. A two-
tailed P-value of 0.05 was considered statistically significant.
Results
Study cohort
The CONFIRM registry screened 27 125 CCTA patients at 12 par-
ticipating centres in six countries. Patients were followed for a
median of 2.1 years (interquartile range 1.5–3.1 years). A total of
956 (3.5%) patients were lost to follow-up; for 20 743 patients, cor-
onary arterydominancepattern hadnot beenevaluated due todiffer-
ent reasons including technical reasons, extensive atherosclerosis,
presence of occluding thrombi with large filling defects distally, or
prior CABG. Thus, the final study population comprised 6382
patients (47% females, 53% males, mean age 56.9+ 12.3 years)
with or without CAD remained for the present analysis and was
included in the study. Table 1 depicts baseline characteristics of the
patient population, categorized by coronary vessel dominance. Left
coronary dominance (LCD) patients tend to have a higher BMI
(27.8+ 5.4 vs. 27.2+ 5.3, P ¼ 0.0288), and were more often male
(62 vs. 38%, P, 0.0001) and asymptomatic (24 vs. 37%, P ¼
0.0003) than patients with right coronary dominance (RCD).
CCTA findings
Right dominance was present in 91% (n ¼ 5817) and left dominance
in 9% (n ¼ 565) of the study population. Normal coronary arteries
were found by CCTA in 3361 (53%) patients, non-obstructive
CAD in 1787 (28%), obstructive CAD in 457 (7%), and severe ob-
structive in 776 (12%; Table 2). Patients with left dominance tend
to have a lower Agatston score than those with right dominance
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Table 1 Baseline characteristics of the study population by dominance
Patient characteristics Total (n 5 6382) Right dominant (n5 5817) Left dominant (n5 565) P-value
Male gender 3343 (53%) 2995 (51%) 348 (62%) ,0.0001
BMI 27.3+5.3 27.2+5.3 27.8+5.4 0.0288
Age (years) 56.9+12.3 56.9+12.2 56.6+13.0 0.1726
Hypertension 3287 (52%) 2970 (52%) 317 (56%) 0.0453
Diabetes 757 (12%) 680 (12%) 77 (14%) 0.1799
Dyslipidaemia 3373 (54%) 3093 (54%) 280 (50%) 0.0742
Current smoking 1231 (19%) 1111 (19%) 120 (21%) 0.246
Family history of CAD 2036 (33%) 1839 (33%) 197 (36%) 0.2314
Symptoms
Asymptomatic 2114 (34%) 1913 (24%) 201 (37%) 0.0003
Non-Cardiac 977 (16%) 868 (15%) 109 (20%)
Atypical 2230 (36%) 2077 (37%) 153 (28%)
Typical 825 (13%) 747 (13%) 78 (14%)
Dyspnoea 1793 (31%) 1611 (31%) 182 (35%) 0.0383
Diamond and Forrester pre-test probability 32.9+29.2 33.0+29.1 32.5+29.8 0.69
Morise score 11.9+4.3 11.8+4.3 12.0+4.2 0.56
Data are presented as n (%) and mean+ SD. Patients with a balanced coronary artery system were excluded from the analysis.
BMI, body mass index; CAD, coronary artery disease.
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(420.0 in the right dominance and 363.0 in the left dominance,
P, 0.0001, median comparison test; Table 2). In our study cohort,
648 (10%) patients had one-vessel disease, 351 (10%) had two-vessel
disease, and 222 (3%) were diagnosed with three-vessel disease. The
severity of CAD and stenosis location on CCTA differed significantly
among patients with a left dominant and right dominant coronary
artery system: patients with left dominance tend to have more non-
obstructive CAD (35 vs. 27%, P, 0.0001) and significant stenosis
in the left anterior descending or circumflex artery (19 vs. 14%,
P ¼ 0.0067 and 10 vs. 7%, P ¼ 0.0203, respectively), whereas
patients with right dominance tend to have more often normal cor-
onary arteries (54 vs. 43%, P, 00001) or obstructive CAD in the
RCA (10 vs. 5%, P, 0.0001; Table 2).
Event and survival rate
During a follow-up of 60 months, the composite endpoint occurred
in 321 (5.0%) patients. All-cause mortality was reported in 100 (1.6%)
patients, non-fatal MI occurred in 131 (2.1%), and 120 patients (1.9%)
underwent revascularization. When comparing event-free survival
during 5 years of follow-up in patients with normal coronary arteries
according to coronary vessel dominance, survival rates for the cumu-
lative incidence of all-cause mortality, non-fatal MI, and coronary
revascularization did not significantly differ between patients with
LCD or RCD (log-rank P ¼ 0.14, Figure 1B), with low cumulative
event rates of 1.7 and 0.9%, respectively. Similar results were
obtained when a separate analysis for each endpoint in patients
with normal coronary arteries was conducted (log-rank P ¼ 0.41
for all-cause mortality, log-rank P ¼ 0.13 for MI, and P ¼ 0.73 for cor-
onary revascularization, data not shown). Likewise, in patients with
significant CAD (.50% stenosis), no significant difference was
observed in event-free survival between left dominant and right dom-
inant coronary artery systems, with cumulative event rates of 18.8
and 19.1% after5 years of follow-up for a right- and left dominant cor-
onary artery system, respectively (log-rank P ¼ 0.84, Figure 1A).
These results remained the same when a separate analysis for each
endpoint in patients with significant CAD was conducted (log-rank
P ¼ 0.069 for all-cause mortality, log-rank P ¼ 0.63 for MI, and P ¼
0.76 for coronary revascularization, data not shown) or when
patients with obstructive CAD (stenosis 50–70%; log-rank P ¼
0.60, data not shown) or severe obstructive CAD (stenosis .70%;
log-rank 0.92, data not shown) were analysed separately. When
stratified for sex, patients with LCD and RCD showed similar survival
rates for the incidence of all-cause mortality, non-fatal MI, and coron-
ary revascularization (log-rank P ¼ 0.72 for males and log-rank P ¼
0.3842 for females; Figure 2A and B).
Prognostic value of coronary dominance
Uni- andmultivariableproportionalhazardsmodels confirmedthatob-
structiveand severeobstructiveCADinbothcoronary variationswere
predictors of all-cause mortality, non-fatal MI, and revascularization,
and had an incremental value over clinical variables (Table 3). In
patients with non-obstructive CAD, a right dominant system was
identified as a significant predictor of the combined endpoint when
compared with patients without coronary artery atherosclerosis
[hazard ratio (HR) 4.78, 95% CI 3.01–7.59, P, 0.0001, Table 3]
and remained a significant predictor after correction for baseline
risk factors (P, 0.0001), whereas left dominance did not predict
any events in this subpopulation (HR 2.79, 95% CI 0.77–10.1,
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Table 2 CCTA results: prevalence of coronary dominance in the study population
CCTA findings Total (N 5 6382) Right dominant (n5 5817) Left dominant (n5 565) P-value
Agatston score (mean+ SD)a 141.3+415 141.1+420.0 144.2+363.0 ,0.001b
Number of obstructive vessels
None/normal 3361 (53%) 3119 (54%) 242 (43%) ,0.0001
Non-obstructive 1788 (28%) 1591 (27%) 197 (35%)
One-vessel CAD 636 (10%) 563 (10%) 73 (13%)
Two-vessel CAD 325 (5%) 289 (5%) 36 (6%)
Three-vessel/LM CAD 272 (4%) 255 (4%) 17 (3%)
Level of obstructive CAD
Normal 3361 (53%) 3119 (54%) 242 (43%) ,0.0001
Non-obstructive (1–49%) 1788 (28%) 1591 (27%) 197 (35%)
Obstructive CAD (50–70%) 457 (7%) 408 (7%) 49 (9%)
Severe obstructive CAD (.70%) 776 (12%) 699 (12%) 77 (14%)
Left main .50% 85 (1%) 76 (1%) 9 (2%) 0.5423
LAD .50% 939 (15%) 834 (14%) 105 (19%) 0.0067
LCx .50% 465 (7%) 410 (7%) 55 (10%) 0.0203
RCA .50% 602 (9%) 576 (10%) 26 (5%) ,0.0001
Data are presented as mean (+SD) or n (%). Patients with a balanced coronary artery system were excluded from the analysis.
CCTA, coronary computed tomographic angiography; CAD, coronary artery disease; LCx, left circumflex artery; RCA, right coronary artery; LM, left main artery; LAD, left anterior
descending artery.
aMissing in 1309 patients.
bP value given for median Agatston score (non-normal distribution of data).
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Figure 1 (A) Event-free survival (Kaplan–Meier curve) from major adverse events (all-cause mortality, non-fatal MI, and coronary revasculariza-
tion) with follow-up extending to 5 years in patients with RCD and LCD stratified for the presence of obstructive CAD (.50%) on CCTA. Patients
with a balanced coronary artery system were excluded from the analysis, because of the low number of patients in this group. (B) Event-free survival
(Kaplan–Meier curve) from major adverse events (all-cause mortality, non-fatal MI, and coronary revascularization) in patients with RCD and LCD
stratified for normal coronary arteries. Patients with a balanced coronary artery system were excluded from the analysis, because of the low number
of patients in this group.
Figure 2 (A) Males: event-free survival (Kaplan–Meier curve) from major adverse events (all-cause mortality, non-fatal MI, and coronary revas-
cularization) with follow-up extending to 5 years stratified by coronarydominance in patients with obstructive CAD(.50%) on CCTA. (B) Females:
event-free survival (Kaplan–Meier curve) from major adverse events (all-cause mortality, non-fatal MI, and coronary revascularization) with follow-
up extending to 5 years stratified by coronary dominance in patients with obstructive CAD (.50%) on CCTA. Patients with a balanced coronary
artery system were excluded from the analysis.
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P ¼ 0.1172, Table 3). When female and male patients were analysed
separately, results remained the same (P, 0.0001 for females with
RCD patients and non-obstructive CAD and P, 0.0001 for males
with RCD patients and non-obstructive CAD, data not shown).
We further assessed the difference in a prognostic value between
left and right coronary vessel dominance in patients with obstructive
CAD for the composite endpoint of all-cause mortality, non-fatal MI,
and coronary revascularization: Cox regression model analysis
showed that the difference in the risk estimate of obstructive CAD
between patients with a right dominant and those with a left domin-
ant coronary artery system was statistically not significant (HR 1.04,
95% CI 0.68–1.59, P ¼ 0.8461, right vs. left dominant, Table 4). Simi-
larly, in patients with normal coronary arteries or non-obstructive
CAD,nodifference in the predictivevalue between the twocoronary
dominance pattern was found (HR 0.46, 95% CI 0.16–1.32,
P ¼ 0.1496 and HR 0.95, 95% CI 0.41–2.21, P ¼ 0.8962, right vs.
left dominant, respectively, Table 4).
Furthermore, significant CAD in one vessel was also identified as a
predictor for the combined endpoint with a HR of 16.92 (95% CI
5.5–52.1, P, 0.0001 vs. normal coronary arteries) in the left dom-
inant system and a HR of 24.43 (95% CI 15.9–37.5, P, 0.0001 vs.
normal coronaryarteries) in the right dominant system.Consequent-
ly, in both uni- and multivariable models accounting for individual
Framingham risk factors, the risk was dose-dependently increased
when more vessels were affected (data not shown).
Prognostic value of significant stenosis
location
After stratification according to stenosis location, the rate of cumu-
lative event for LCD patients with significant LAD stenosis was 8%
for non-fatal MI, 9% for coronary revascularization, and 8% for
all-cause mortality (Figure 3A), whereas in patients with right domin-
ance and significant RCA stenosis event rates for non-fatal MI,
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Table 4 Uni- and multivariate analyses adjusted by Framingham risk factors including age, sex, hypertension, diabetes
mellitus, current smoking, and dyslipidaemia
Univariate Multivariate (CAD RF adjusted)
HR 95% CI P-value HR 95% CI P-value
Normal coronary artery
Right dominant (vs. left dominant) 0.46 0.16–1.32 0.1496 NS NS NS
Non-obstructive CAD
Right dominant (vs. left dominant) 0.95 0.41–2.21 0.8962 NS NS NS
Obstructive CAD
Right dominant (vs. left dominant) 1.04 0.68–1.59 0.8461 NS NS NS
HRs of RCD vs. LCD for the composite outcome of all-cause mortality, non-fatal MI, and coronary revascularization according to the extend of CAD (non-obstructive: ,50%
stenosis, obstructive: .50% stenosis) on CCTA. Patients with a balanced coronary artery system were excluded from the analysis.
CAD, coronary artery disease; RF, risk factor; HR, hazard ratio; CI, confidence interval.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Uni- and multivariate analyses adjusted by Framingham risk factors including age, sex, hypertension, diabetes
mellitus, current smoking, and dyslipidaemia
Univariate Multivariate (CAD RF adjusted)
HR 95% CI P-value HR 95% CI P-value
Left dominant
None/normal 1 Reference Reference 1 Reference Reference
Non-obstructive 2.79 0.77–10.1 0.1172 1.67 0.34–8.27 0.5278
Obstructive (50–70%) 10.31 2.88–36.8 0.0003 9.75 2.10–45.2 0.0036
Severe obstructive (.70%) 20.67 6.81–62.8 ,0.0001 18.16 4.19–78.8 0.0001
Right dominant
None/normal 1 Reference Reference 1 Reference Reference
Non-obstructive 4.78 3.01–7.59 ,0.0001 3.39 2.06–5.59 ,0.0001
Obstructive (50–70%) 23.38 14.9–36.7 ,0.0001 15.08 9.12–24.9 ,0.0001
Severe obstructive (.70%) 35.58 23.7–53.4 ,0.0001 22.83 14.2–36.8 ,0.0001
HRs of CAD (non-obstructive:,50% stenosis, obstructive: .50%stenosis, severe obstructive: .70%stenosis) for the composite outcome of all-cause mortality, non-fatal MI, and
coronary revascularization in LCD and RCD compared with normal coronary arteries on CCTA. Patients with a balanced coronary artery system were excluded from the analysis.
CAD, coronary artery disease; RF, risk factor; HR, hazard ratio; CI, confidence interval.
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coronary revascularization, and all-cause mortality were 10, 12, and
4%, respectively (Figure 3B). A significant stenosis in the left coronary
system (LAD and LCx) was observed in 1489 patients and was asso-
ciated with an increased riskof the combined endpoint all-cause mor-
tality, non-fatal MI, and coronary revascularization for left dominance
(HR 7.01 for LAD and 3.83 for LCx) as well as for right dominance
(HR 10.12 for LAD and 8.29 for LCx, Table 5, lower panel).
However, significant left main disease was observed in 85 patients
and the presence of LM disease conferred an increased HR for the
combined adverse event by 6.45 after multivariable adjustment
(95% CI 1.66–25.0, P ¼ 0.007) in patients with left dominance. In
right dominance, however, LM disease was not significantly asso-
ciated with the composite prognosis endpoint (HR 1.35, 95% CI
0.73–2.51, P ¼ 0.3456 after adjustment for CAD and risk factors;
Figure 3 (A) Risk estimates for all-cause mortality, non-fatal MI, and coronary revascularization in patients with significant LAD stenosis and a left
dominant system. Patients with a balanced coronary artery system were excluded from the analysis. (B) Risk estimates for all-cause mortality, non-
fatal MI, and coronary revascularization in patients with significant RCA stenosis and a right dominant system.
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Table 5 Upper and lower panels: Uni- andmultivariate analyses adjusted by Framingham risk factors including age, sex,
hypertension, diabetes mellitus, current smoking, and dyslipidaemia
Univariate Multivariate (CAD RF adjusted)
HR 95% CI P-value HR 95% CI P-value
Upper panel
Left dominant
None/normal 1 Reference Reference 1 Reference Reference
Non-obstructive 2.76 0.77–9.92 0.1209 1.75 0.35–8.71 0.4975
One-vessel disease 16.92 5.50–52.1 ,0.0001 16.27 3.81–69.4 0.0002
Right dominant
None/normal 1 Reference Reference 1 Reference Reference
Non-obstructive 4.8 3.02–7.63 ,0.0001 3.5 2.12–5.77 ,0.0001
One-vessel disease 24.43 15.9–37.5 ,0.0001 15.91 9.79–25.8 ,0.0001
Left dominant
LM .50% 9.02 2.71–30.0 0.0003 6.45 1.66–25.0 0.007
RCA .50% 5.34 2.19–13.0 0.0002 3.49 1.29–9.47 0.0141
Right dominant
LM .50% 4.13 2.37–7.22 ,0.0001 1.35 0.73–2.51 0.3456
RCA .50% 10.33 8.16–13.1 ,0.0001 5.7 4.27–7.59 ,0.0001
HRs of CAD according to (upper panel) the amount of diseased vessels (one-, two-, and three-vessel disease) and (lower panel) the stenosis location for the composite outcome of
all-cause mortality, non-fatal MI, and coronary revascularization in LCD or RCD compared with normal coronary arteries on CCTA.
LM, left main artery; RCA, right coronary artery; CAD, coronary artery disease; RF, risk factor; HR, hazard ratio; CI, confidence interval.
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Table 5, lower panel). A significant lesion in the right system was asso-
ciated with an increased risk of the composite endpoint in left dom-
inance (HR 3.49, 95% CI 1.29–9.47, P ¼ 0.0141) as well as in right
dominance (HR 5.7, 95% CI 4.27–7.59, P, 0.0001, Table 5, lower
panel).
Discussion
In this prospective multicentre study, we systematically evaluated the
prognostic value of coronary dominance assessed by CCTA in a large
cohort of patients. When comparing event-free survival in patients
with normal coronary arteries or obstructive CAD according to cor-
onary vessel dominance, survival rates for the cumulative incidenceof
all-cause mortality, non-fatal MI, and coronary revascularization after
5 years of follow-up did not differ significantly between patients with
LCD or RCD.
In our study, right dominance was present in 91% and left domin-
ance in 9%, which is not significantly different from values given in the
literature, varying from 8.2 to 15% for left dominance and from 72 to
90% for right dominance.10– 12,23,24 Left dominance was observed
more often in males (62%) compared with females (38%), while pre-
vious retrospective studies indicate that there is no difference in cor-
onary dominance with regard to gender.23,25 –27 However, these
differences may arise due to different selection of patients, e.g. the
inclusion of low-to-intermediate risk patients at an advanced age in
the present study.
In contrast to our findings, two previous retrospective angiograph-
ic studies using cardiac catheterization databases in patients with ACS
have shown that left dominance was associated with modestly
increased odds of death during a 3.5-year follow-up (HR 1.13;
1.00–1.28) or in-hospital mortality (HR 1.19; 1.06–1.34) following
PCI, respectively.12,13 Nevertheless, those studies were retrospect-
ive analyses done on conventional angiograms and the study popula-
tion consisting of high-risk ACS patients and patients with prior
coronary artery bypass graft differed substantially from our study
population. In a recent prospective study of 1425 patients referred
for CCTA, non-fatal MI and all-cause mortality were increased (HR
3.15) in patients with left dominance during a 2-year follow-up
period.28 However, potential selection bias due to smaller patient
numbers in this study cannot be excluded, and no differences in prog-
nosis for different coronary dominance patterns were observed
when coronary revascularization was included in the combined
primary endpoint. Taken together, it seems that left dominance
may have different prognostic values regarding short- and long-term
mortality in patients with ACS compared with patients with stable
CAD, thereby, emphasizing the importance of angiographic interven-
tions in left dominance patients with ACS. However, prospective
studies in patients with ACS are needed to confirm this.
At present, little is known about the prognostic value of stenosis
location in relation to coronary vessel dominance, and only one
recent study in 1425 patients referred for CCTA demonstrated
that a stenosis in the left coronary system was associated with an
increased risk of events, while a stenosis in the RCA did not statistic-
ally significant predict events.28 Our analysis among subgroups with
left main disease showed an elevated hazard of the combined end-
point for left dominance that was statistically significant while a sten-
osis in the left main did not predict events in right dominance. This
finding is consistent with previous observations in patients undergo-
ing PCI for ACS.13 Coronary vessel dominance has influence on the
relativecontribution of the different coronaryarteries to the total left
ventricular blood flow29 and in most individuals with LCD, the RCA is
usually small and often fails to reach the acute margin of the heart.
Thus, a proximal stenosis of the left coronary artery may result in
more extensive ischaemia and worse consequences in a left domin-
ant system than in a right dominant system. In addition, the potential
to rapidly form collaterals might be diminished in patients with a left
dominant coronary artery system due to the fact that the RCA is not
sufficient to perfuse the myocardium.30 However, to date, the under-
lying pathophysiology has not been investigated and further research
is needed to assess the effect modification by culprit lesion site or
coronary collateral formation in patients with left main disease and
left coronary system.
The relationship between coronary vessel dominance and the
extent of CAD remains uncertain as different studies showed oppos-
ing results. Indeed, one previous study has shown that LCD was
associated with a higher incidence of atherosclerosis,31 whereas
others showed more extensive CAD in patients with a right domin-
ant coronary artery system12,23 or did not detect differences in the
extent of CAD between LCD or RCD.26,28 However, this discrep-
ancy can most likely be explained by a potential selection bias due
to small study populations, and the differences in modalities used
for the assessment of CAD in these studies. In the present study,
we observed a higher incidence of CAD (obstructive and non-
obstructive) in left dominance patients, whereas the prevalence of
normal coronary arteries was more frequent in right dominance.
However, no difference in predisposition to three-vessel disease
was seen between LCD or RCD which strongly supports the hypoth-
esis that dominance pattern does not predict outcomes in patients
with CAD.
Interestingly, in patients with non-obstructive CAD, a right domin-
ance system was identified as a significant predictor of the combined
endpoint, whereas left dominance did not predict any events in this
subpopulation. The possibility that intermediate lesions may carry
an increased risk in right dominant circulations is of particular
importance since it would challenge the current paradigm of non-
intervention for these non-obstructive lesions. However, there was
no statistically significant difference in univariate analysis in this sub-
group when right dominance was compared with left dominance.
Yet, our study was likely statistically underpowered to detect effect
modification between left and right dominance in this subgroup
with non-obstructive CAD.
As with any study, certain design limitations are inherent. Of note
is the low prevalence of left and co-dominant coronary circulation
in the general population. While our study was sufficiently
powered to detect an effect size in LCD, we did not include patients
with co-dominant circulation in our analysis, since our study was
underpowered to detect statistical effect modification in this sub-
group. Secondly, as with any observational, open-label registry,
potential heterogeneity between sites, interobserver and intersite
variability in CCTA diagnosis, and different post-CCTA treatment
patterns cannot be excluded. Thirdly, in the CONFIRM registry,
CAD was defined using CCTA and not using invasive coronary angi-
ography or other imaging modalities; therefore, the possibility of
false-positive or false-negative CCTA findings exists despite the
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performance of CCTA by international experts. Finally, information
regarding the coronary dominance pattern was not uniformly avail-
able for our study cohort, since not all CONFIRM sites collected
this information. Thus, the final study comprised only 23.5% of the
entire CONFIRM population and, as such, may have the potential
for selection bias which may limit the generalizability of the data.
However, our study population is the largest, presently available pro-
spective CCTA cohort evaluating the predictive value of coronary
dominance and may therefore provide solid data and good evidence
regarding the prognostic information of coronary dominance.
In conclusion, our findings suggest that that the assessment of cor-
onary vessel dominance by CCTA may not enhance the risk stratifi-
cation beyond the assessment of the degree of stenosis in patients
with normal coronary arteries or obstructive CAD referred for
CCTA, but may add prognostic information for specific subpopula-
tions such as patients with left main disease or non-obstructive CAD.
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Transthoracic three-dimensional echocardiography visualization of
functional anatomy of double-orifice mitral valve
Davide Ermacora, Denisa Muraru, Antonella Cecchetto, Umberto Cucchini, and Luigi P. Badano*
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A 14-year-old boy was referred to our
echocardiography laboratory because of a
recent history of palpitations. Both physical
examination and ECG were unremarkable.
An ambulatory ECG recording detected
only rare supraventricular ectopic beats.
A two-dimensional transthoracic echocar-
diogram (2DE, Panel A, see Supplementary
data online, Video S1) raised the suspect of
a double-orifice mitral valve (DOMV), with-
out either stenosis or regurgitation at colour
and spectral Doppler analyses (Panel B).
Three-dimensional transthoracic echocar-
diography (3DE) visualization of the valve
from both ventricular and atrial perspectives
(Panels C and D, see Supplementary data
online, Videos S2 and S3) clearly showed the
doubleorifices (white *)withacentralbridge
of abnormal tissue connecting the anterior
with the posterior leaflet. The two orifices
were asymmetric, being the medial orifice
slightly larger than the lateral one. Valvular
leaflets were thin and normally sized. Therewere two papillary muscles that showed normal morphologyand position. No other combined
congenital abnormalities were detected. The patient was discharged without performing additional tests and no prescription.
*,mitral valve orifice;AML, anterior mitral leaflet; AV, aortic valve; IAS, interatrial septal defect; LAA, left atrial appendage; PML, posterior
mitral leaflet; RV, right ventricle.
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